Shionogi. has filed a patent for Diels-Alder adducts of chalcone and prenylphenyl moieties that modulate cannabinoid receptors and flavan-3-ol oligomers that modulate fat absorption. The patent also covers compositions combining these compounds with weight management agents for treating obesity and promoting weight loss. GlobalData’s report on Shionogi gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Shionogi & Co Ltd - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Shionogi, Cancer treatment biomarkers was a key innovation area identified from patents. Shionogi's grant share as of January 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.

Weight management composition containing morus, magnolia, and yerba mate extracts

Source: United States Patent and Trademark Office (USPTO). Credit: Shionogi & Co Ltd

The patent application US20240024403A1 discloses a composition comprising a mixture of Morus extract enriched for Diels-Alder adducts of a chalcone and a prenylphenyl moiety, Magnolia extract, and Yerba Mate extract. The composition includes specific compounds and extracts from Morus alba, Magnolia officinalis, and Ilex paraguayensis, enriched for various active ingredients such as Albanin G, magnolol, and caffeine. The formulation can be further combined with a carrier, diluent, or excipient for pharmaceutical or nutraceutical use, with the active ingredients ranging from 0.5% to 90% of the mixture.

Additionally, the patent application includes variations of the composition, such as one including Mutamba extract instead of Magnolia extract, or Rosemary extract in place of Magnolia extract. These compositions also contain specific compounds and extracts enriched for various active ingredients, formulated with a carrier, diluent, or excipient for pharmaceutical or nutraceutical use. The application also outlines methods for maintaining body weight, promoting a healthy lipid profile, and treating weight gain in mammals by administering the disclosed compositions, providing potential applications for the developed formulations in the field of health and wellness.

To know more about GlobalData’s detailed insights on Shionogi, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies